Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News: Jan 14, 2010

Premium

Seegene said this week that Health Canada has granted it a Medical Device License for its Seeplex Diarrhea-V ACE Detection test.

The company said that the multiplex assay uses proprietary PCR technology to simultaneously amplify target pathogens. The test detects a range of viral pathogens that cause diarrhea, including enteric adenovirus, Group A rotavirus, Norovirus GI/GII, and Astrovirus

The license from Health Canada is the first approval for the test in North America. It is already CE-Marked for use in Europe.


Enzo Biochem said this week that its Enzo Clinical Labs division is now providing Roche Diagnostics' H1N1 PCR test for physicians throughout the Metropolitan New York, including New Jersey and parts of Pennsylvania.

Roche gained an Emergency Use Authorization from the US Food and Drug Administration for its RealTime ready Influenza A/H1N1 Detection Set last November.

The kit detects RNA from the 2009 H1N1 influenza A virus and is used in conjunction with Roche's RealTime ready RNA Virus Master kit.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.